Get started
Author

Thamil Annamalai

Observed names: Annamalai Thamil, T. Annamalai, THAMIL ANNAMALAI
OpenAlex ID: A5085787188
XP13512 [(±)-1-([(α-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: II. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared with Gabapentin in Rats and Monkeys
2004 · Kenneth C. Cundy, Thamil Annamalai, et al. · Journal of Pharmacology and Experimental Therapeutics · 121
Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen
2009 · Ritu Lal, Juthamas Sukbuntherng, et al. · Journal of Pharmacology and Experimental Therapeutics · 85
Discovery of a novel potent GABAB receptor agonist
2011 · Feng Xu, Ge Peng, et al. · Bioorganic & Medicinal Chemistry Letters · 24
Discovery of MC-02,331, a New Cephalosporin Exhibiting Potent Activity Against Methicillin-resistant Staphylococcus aureus.
1998 · SCOTT J. HECKER, IN-SEOP CHO, et al. · The Journal of Antibiotics · 19
PDF
751 Safety, Tolerability, and Pharmacokinetics of PTG-200, an Oral GI-Restricted Peptide Antagonist of IL-23 Receptor, in Normal Healthy Volunteers
2019 · Xiaoli Cheng, Tien-Yi Lee, et al. · The American Journal of Gastroenterology · 16
P-126 PTG-100, An Oral Peptide Antagonist of Integrin α4β7 that Alters Trafficking of Gut Homing T Cells in Preclinical Animal Models
2016 · Larry Mattheakis, Ashok Bhandari, et al. · Inflammatory Bowel Diseases · 9
P113 Model based predictions of the PTG-100 pharmacodynamic responses in ulcerative colitis patients
2017 · L. Mattheakis, C. Fosser, et al. · Journal of Crohn s and Colitis · 6
Comparative Gastric Irritation of the Fumaric Acid Esters Dimethyl Fumarate (DMF) and XP23829 in Rat and Monkey (P01.159)
2013 · Timothy McCullough, Thamil Annamalai, et al. · Neurology · 5
Hepcidin Mimetic Ptg-300 for Treatment of Ineffective Erythropoiesis and Iron Overload
2017 · Gregory T. Bourne, Li Zhao, et al. · American Journal of Hematology · 3
P-148 Discovery of Novel Oral Peptide Antagonists of IL-23 Receptor that Are Efficacious in a Rat Model of IBD
2016 · Ashok Bhandari, Xiaoli Cheng, et al. · Inflammatory Bowel Diseases · 2
198 - Oral Delivery of Peptides with Dual Mu/Delta Opioid Receptor Agonist Activities are Superior to Eluxadoline in Preclinical Models of IBS-D
2018 · Larry Mattheakis, Sampath-Kumar Anandan, et al. · Gastroenterology
P-271 The Biomarker Profile of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor, Correlates with Efficacy in Preclinical Models of IBD
2017 · Xiaoli Cheng, Roopa Taranath, et al. · Inflammatory Bowel Diseases
971f Discovery of Novel and Potent Orally Stable Peptide Antagonistsof the Human IL-23 Receptor and Their Pre-Clinical POC in Rat Colitis Models
2016 · Ashok Bhandari, Xiaoli Cheng, et al. · Gastroenterology
Tu1869 Establishing the Human Equivalent Dose for Ptg-100, an Oral Peptide Antagonist of Integrin α4β7
2016 · Larry Mattheakis, Genet Zemede, et al. · Gastroenterology
O-022 Integrin α4β7
2014 · Mattheakis Larry, Bhandari Ashok, et al. · Inflammatory Bowel Diseases
Properties Compared to R-Baclofen.
2009 · Ritu Lal, Juthamas Sukbuntherng, et al.
Works count: 17
Citation count: 290
H-index: 6
I10-index: 5
Year
Topic
Type